METHOD FOR SELECTING TREATMENT METHOD AND SURGICAL ACCESS IN SUPPURATIVE INFLAMMATORY UTERINE APPENDAGES DISEASES

FIELD: medicine. ^ SUBSTANCE: method involves determining alpha-2-macroglobulin MG and lactoferrine LF in blood serum. Coefficient K value is calculated from formula K=MG/LF. The value being greater than 1.2, no purulent necrotic destruction is considered to be available in uterine appendages and wi...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	ARKHIPOVA SVETLANA VIKTOROVNA, PANCHENKO VALENTINA ALEKSANDROVNA, SHRAMKO SVETLANA VLADIMIROVNA, ZORINA RAISA MIKHAJLOVNA, ZORINA VERONIKA NIKOLAEVNA, KRAJUSHKINA NADEZHDA ALEKSANDROVNA, BAZHENOVA LJUDMILA GRIGOR'EVNA
Format:	Patent
Sprache:	eng ; rus
Schlagworte:	INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING PHYSICS TESTING
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	FIELD: medicine. ^ SUBSTANCE: method involves determining alpha-2-macroglobulin MG and lactoferrine LF in blood serum. Coefficient K value is calculated from formula K=MG/LF. The value being greater than 1.2, no purulent necrotic destruction is considered to be available in uterine appendages and without neighboring organs being dragged into inflammatory process and surgical treatment method with laparoscopic access is to be selected. The value being less than 0.5, generalized purulent destructive is diagnosed and surgical treatment method with laparotomy access is to be selected. ^ EFFECT: improved diagnosis and treatment method.